Opinion: Wilkinson’s October Departure From UK MHRA – Should We Be Concerned?
Executive Summary
The MHRA’s John Wilkinson has arguably been the most high-profile medtech regulator in Europe this decade. Who replaces him and how the UK goes forward are matters of not just national, but also European and international importance, says Medtech Insight’s Amanda Maxwell. Three key regulatory officials add their views too.